SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-000121
Filing Date
2023-01-09
Accepted
2023-01-09 07:00:46
Documents
40
Period of Report
2023-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20230109x8k.htm   iXBRL 8-K 40585
2 EX-99.1 acrs-20230109xex99d1.htm EX-99.1 47238
3 GRAPHIC acrs-20230109xex99d1g008.jpg GRAPHIC 155015
4 GRAPHIC acrs-20230109xex99d1g006.jpg GRAPHIC 161585
5 GRAPHIC acrs-20230109xex99d1g010.jpg GRAPHIC 182315
6 GRAPHIC acrs-20230109xex99d1g002.jpg GRAPHIC 338139
7 GRAPHIC acrs-20230109xex99d1g011.jpg GRAPHIC 138559
8 GRAPHIC acrs-20230109xex99d1g012.jpg GRAPHIC 146108
9 GRAPHIC acrs-20230109xex99d1g018.jpg GRAPHIC 149462
10 GRAPHIC acrs-20230109xex99d1g007.jpg GRAPHIC 78177
11 GRAPHIC acrs-20230109xex99d1g021.jpg GRAPHIC 180795
12 GRAPHIC acrs-20230109xex99d1g026.jpg GRAPHIC 165738
13 GRAPHIC acrs-20230109xex99d1g027.jpg GRAPHIC 85296
14 GRAPHIC acrs-20230109xex99d1g022.jpg GRAPHIC 162622
15 GRAPHIC acrs-20230109xex99d1g015.jpg GRAPHIC 208750
16 GRAPHIC acrs-20230109xex99d1g014.jpg GRAPHIC 80873
17 GRAPHIC acrs-20230109xex99d1g009.jpg GRAPHIC 153801
18 GRAPHIC acrs-20230109xex99d1g004.jpg GRAPHIC 208658
19 GRAPHIC acrs-20230109xex99d1g013.jpg GRAPHIC 169550
20 GRAPHIC acrs-20230109xex99d1g003.jpg GRAPHIC 166110
21 GRAPHIC acrs-20230109xex99d1g019.jpg GRAPHIC 78927
22 GRAPHIC acrs-20230109xex99d1g025.jpg GRAPHIC 187521
23 GRAPHIC acrs-20230109xex99d1g024.jpg GRAPHIC 147875
24 GRAPHIC acrs-20230109xex99d1g005.jpg GRAPHIC 179601
25 GRAPHIC acrs-20230109xex99d1g023.jpg GRAPHIC 67049
26 GRAPHIC acrs-20230109xex99d1g020.jpg GRAPHIC 175532
27 GRAPHIC acrs-20230109xex99d1g001.jpg GRAPHIC 170704
28 GRAPHIC acrs-20230109xex99d1g016.jpg GRAPHIC 154266
29 GRAPHIC acrs-20230109xex99d1g017.jpg GRAPHIC 135293
  Complete submission text file 0001558370-23-000121.txt   6048656

Data Files

Seq Description Document Type Size
30 EX-101.SCH acrs-20230109.xsd EX-101.SCH 3052
31 EX-101.LAB acrs-20230109_lab.xml EX-101.LAB 16010
32 EX-101.PRE acrs-20230109_pre.xml EX-101.PRE 10317
34 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20230109x8k_htm.xml XML 4794
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 23516492
SIC: 2834 Pharmaceutical Preparations